However, whether PTH interplays in the established pathogenesis of sarcopenia and myocyte changes, such as oxidative stress, inflammation, mitochondrial and satellite cell dysfunction, and myostatin overexpression, remains unexplored and should be addressed in further research. Here, MSTN is linked to sarcopenia.